BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36522238)

  • 21. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study.
    Heigl T; Kaes J; Aelbrecht C; Serré J; Yamada Y; Geudens V; Van Herck A; Vanstapel A; Sacreas A; Ordies S; Frick A; Saez Gimenez B; Van Slambrouck J; Beeckmans H; Acet Oztürk NA; Orlitova M; Vaneylen A; Claes S; Schols D; Vande Velde G; Schupp J; Kaminski N; Boesch M; Korf H; van der Merwe S; Dupont L; Vanoirbeek J; Godinas L; Van Raemdonck DE; Janssens W; Gayan-Ramirez G; Ceulemans LJ; McDonough JE; Verbeken EK; Vos R; Vanaudenaerde BM
    Front Immunol; 2024; 15():1369536. PubMed ID: 38736881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Profiling in Lung Biopsies of Human Pulmonary Allografts to Predict Chronic Lung Allograft Dysfunction.
    Jonigk D; Izykowski N; Rische J; Braubach P; Kühnel M; Warnecke G; Lippmann T; Kreipe H; Haverich A; Welte T; Gottlieb J; Laenger F
    Am J Pathol; 2015 Dec; 185(12):3178-88. PubMed ID: 26476349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.
    Watanabe T; Martinu T; Chruscinski A; Boonstra K; Joe B; Horie M; Guan Z; Bei KF; Hwang DM; Liu M; Keshavjee S; Juvet SC
    Am J Transplant; 2019 Dec; 19(12):3377-3389. PubMed ID: 31365766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction.
    Beeckmans H; Bos S; Vos R; Glanville AR
    Clin Chest Med; 2023 Mar; 44(1):137-157. PubMed ID: 36774160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
    Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF
    Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 29. Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.
    Lynch TJ; Ahlers BA; Swatek AM; Ievlev V; Pai AC; Brooks L; Tang Y; Evans IA; Meyerholz DK; Engelhardt JF; Parekh KR
    Transplantation; 2022 Oct; 106(10):1974-1989. PubMed ID: 35442232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation.
    Yu J; Xu H; Cui J; Chen S; Zhang H; Zou Y; Zhao J; Le S; Jiang L; Chen Z; Liu H; Zhang D; Xia J; Wu J
    Aging (Albany NY); 2020 Jun; 12(12):11636-11652. PubMed ID: 32541091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update in Chronic Lung Allograft Dysfunction.
    Shah RJ; Diamond JM
    Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
    Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
    Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.
    Watanabe T; Lam C; Oliver J; Oishi H; Teskey G; Beber S; Boonstra K; Mauricio Umaña J; Buhari H; Joe B; Guan Z; Horie M; Keshavjee S; Martinu T; Juvet SC
    Mucosal Immunol; 2023 Apr; 16(2):104-120. PubMed ID: 36842540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of stromal cell Thy-1 plays a critical role in lipopolysaccharide induced chronic lung allograft dysfunction.
    Hata A; Guo Y; Miller AE; Hata M; Mei Z; Manafi A; Li D; Banerjee A; Lazear E; Lau C; Gelman AE; Kreisel D; Yoshino I; Wilkes D; Barker TH; Krupnick AS
    J Heart Lung Transplant; 2022 Aug; 41(8):1044-1054. PubMed ID: 35691796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.